Navigation Links
Targeted investigational therapy potential to overcome crizotinib resistance in lung cancers
Date:10/20/2013

in patients with lung cancer. They then showed that PF-06463922 inhibited the growth of tumors harboring three of the crizotinib-resistant ALK mutants, including the most resistant ALK mutant, G1202R, in mice.

Further analysis indicated that PF-06463922 readily entered the brains of mice, rats, and dogs. In mice, levels of PF-06463922 in the brain were 20-30 percent of levels of PF-06463922 in the blood. This is potentially clinically relevant because a significant number of lung cancer patients will develop brain metastasis during the course of their disease, according to Smeal, although he noted that it will be important to see if these results in animals hold true in humans.

Smeal and colleagues also found that PF-06463922 potently inhibited the protein ROS1, a close relative of ALK recently implicated in a number of cancer types, including some lung and brain cancers. Further, PF-06463922 had antitumor effects in two mouse models of cancers driven by ROS1 gene abnormalities, leading the researchers to suggest that PF-06463922 has potential as a treatment for this subgroup of cancers, in addition to its promise as a new treatment for ALK-driven cancers.


'/>"/>

Contact: Lauren Riley
lauren.riley@aacr.org
215-446-7155
American Association for Cancer Research
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Targeted therapeutics for colon cancer to be presented at AACR meeting
2. First targeted nanomedicine to enter human clinical studies
3. Highly targeted irradiation as good as whole breast radiotherapy in early stage cancer
4. Dana-Farber: Study reports first success of targeted therapy in type of non-small cell lung cancer
5. Inflammatory pathway spurs cancer stem cells to resist HER2-targeted breast cancer treatment
6. Killer infections targeted by hospital study
7. Lower risk of serious side-effects in trials of new targeted drugs
8. Treating drug resistant cancer through targeted inhibition of sphingosine kinase
9. Pitt: Targeted oxidation-blocker prevents secondary damage after traumatic brain injury
10. Deadly witch hunts targeted by grassroots womens groups
11. Large lung cancer study shows potential for more targeted therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Anik Singal's Profit Academy ... online marketers has become the talk of the ... attention surrounding the course's general release has garnered ... prompting her to review the program's content and ... the biggest keys to success with Internet marketing ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 On February ... complaint in the United States District Court for the ... Financial Freedom, as well as insurance companies Balboa, QBE, ... 2015 in Case No. 3:14-cv-152.) , The Plaintiff, a ... insurance companies to force her to buy too much ...
(Date:3/3/2015)... Diamond Bar, Calif. (PRWEB) March 03, 2015 ... a leading provider of enterprise Time and Attendance ... has successfully migrated to NOVAtime SaaS Workforce ... automate its time and attendance processes. , ... provide those with developmental disabilities with the best ...
(Date:3/3/2015)... New York, New York (PRWEB) March 03, 2015 ... that question tactics used to market the atypical ... around the U.S. According to court documents, the ... jury’s 2011 finding that Johnson & Johnson’s Janssen ... concealed its serious risks. However, while the Court’s ...
(Date:3/3/2015)... Hollywood, California (PRWEB) March 03, 2015 ... was transformed into the fabulous EcoLuxe Lounge, a day-long ... sustainable and socially conscious products and services. Organized by ... product TV and film placement producer, the EcoLuxe Lounge ... the star of roles on General Hospital, The Flash, ...
Breaking Medicine News(10 mins):Health News:Anik Singal's Profit Academy - Review Of New IM Training Program Released 2Health News:Borrower Accuses Mortgage Lenders of Racketeering in Forcing Insurance on Homeowners 2Health News:Innovative Services, Inc. Successfully Migrates to Cloud-Based NOVAtime Workforce Management Solution to Support Growth and Improve Payroll Processing Time 2Health News:Innovative Services, Inc. Successfully Migrates to Cloud-Based NOVAtime Workforce Management Solution to Support Growth and Improve Payroll Processing Time 3Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 3Health News:Hollywood Star Chase Masterson and Choices Recovery Discuss Substance Abuse and Treatment at 2015 Oscars 2
... Jenifer Goodwin HealthDay Reporter , MONDAY, May 21 ... some artificial sweeteners, may worsen Crohn,s disease by encouraging the ... new study suggests. However, researchers stressed that the findings ... not in people, so it,s too soon to advise those ...
... fat removal procedures are beneficial for treating obesity and reducing ... can,t answer that question. They know that obesity increases the ... have not been clinical studies to determine if the surgical ... In animal studies, however, Rutgers scientists, who have published ...
... ATLANTA A team of researchers, including a scientist ... have found that a type of herpesvirus infection of ... (AMD), a disease that causes blindness in the elderly. ... of herpesvirus, causes the production of vascular endothelial growth ...
... Heart disease risk assessment tools commonly used by ... rheumatoid arthritis patients, a Mayo Clinic study ... in putting those with rheumatoid arthritis in greater jeopardy ... methods do not factor it in, the researchers note. ...
... Cincinnati design students Alex Broerman and Ashley Ma are on ... prescription-medicine pill bottle that better serves the needs of the ... inexpensive innovation. In fact, the two students have filed ... intended to have universal appeal but to fill the special ...
... distinction went to John Edward Solder, a senior at ... Optogenetic Interrogation of Prefrontal Cortex Dopamine D1 Receptor-Containing Neurons ... to Treat Prefrontal Disorders. The 18-year-old was able to ... modified to activate dopamine neurons in the prefrontal cortex, ...
Cached Medicine News:Health News:Could Compound in Artificial Sweeteners Worsen Crohn's Disease? 2Health News:Could Compound in Artificial Sweeteners Worsen Crohn's Disease? 3Health News:Surgical removal of abdominal fat reduces skin cancer in mice 2Health News:Type of viral infection of eye associated with disease causing blindness in the elderly 2Health News:Mayo Clinic: Standard heart disease risk tools underrate danger in rheumatoid arthritis 2Health News:Mayo Clinic: Standard heart disease risk tools underrate danger in rheumatoid arthritis 3Health News:UC students design a better pill bottle for the blind and visually impaired 2Health News:UC students design a better pill bottle for the blind and visually impaired 3Health News:Optogenetics project takes top NIDA Addiction Science Award 2Health News:Optogenetics project takes top NIDA Addiction Science Award 3Health News:Optogenetics project takes top NIDA Addiction Science Award 4
(Date:3/3/2015)... LUMPUR, Malaysia , March 3, 2015 /PRNewswire/ ... the pharmaceutical market. It not only provides containment ... of handling, and proper delivery. As patent loss ... for packaging will steadily rise, in turn encouraging ... customization is further expected to drive the pharmaceutical ...
(Date:3/3/2015)... , March 3, 2015 Actavis plc (NYSE: ... priced an offering of $21 billion aggregate principal amount ... registered public offering to be issued by its indirect ... of its other subsidiaries (the "Notes"), as follows: ... Rate Senior Notes* , $500,000,000 , Due ...
(Date:3/3/2015)... , March 3, 2015  Vermillion, Inc. (NASDAQ: ... today announced management will present at the 27 th ... in Dana Point, California from March ... of Vermillion, Valerie Palmieri , will be presenting on ... joined by Eric Schoen , the company,s Vice President ...
Breaking Medicine Technology:Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 2Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 3Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 4Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 2Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 3Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 4Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 5Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 6Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 7Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 8Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 9Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 10Vermillion To Present at 27th Annual ROTH Conference on March 9 2
... Calif., Nov. 15, 2010 diaDexus, Inc. (OTC Bulletin Board: ... development and commercialization of patent-protected in vitro diagnostic ... results for the third quarter of 2010. Total revenues for ... growth over total revenues of $2.5 million for the third ...
... SPRING, Md., Nov. 15, 2010 The U.S. ... aimed at facilitating the development of safer, more ... rhythms through improved design and manufacturing practices. ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) External ...
Cached Medicine Technology:diaDexus, Inc. Reports 2010 Third Quarter Financial Results 2diaDexus, Inc. Reports 2010 Third Quarter Financial Results 3diaDexus, Inc. Reports 2010 Third Quarter Financial Results 4diaDexus, Inc. Reports 2010 Third Quarter Financial Results 5FDA Launches Initiative to Develop Innovative External Defibrillators 2FDA Launches Initiative to Develop Innovative External Defibrillators 3
... a very versatile light source that ... of applications anytime a Zeiss stereomicroscope ... with optimum protection without heating the ... economical cold-light source that completes a ...
... from a complete line ... AC halogen light sources ... illumination. A solid-state dimmer ... and our exclusive Modulamp ...
Standard 20x long working distance objectives for greater magnifications of your microtools....
These objectives have more contrast than the DLL objectives for enhanced contrast with tissue culture specimens. These objectives are designed for use on inverted microscopes and therefore their mark...
Medicine Products: